表紙
市場調査レポート

Sol-Gel Technologies Ltd. - 製品パイプライン分析

Sol-Gel Technologies Ltd. - Product Pipeline Review - 2014

発行 Global Markets Direct 商品コード 311248
出版日 ページ情報 英文 18 Pages
即納可能
価格
本日の銀行送金レート: 1USD=104.18円で換算しております。
Back to Top
Sol-Gel Technologies Ltd. - 製品パイプライン分析 Sol-Gel Technologies Ltd. - Product Pipeline Review - 2014
出版日: 2014年08月25日 ページ情報: 英文 18 Pages
概要

Sol-Gel Technologies Ltd.スキンケア(皮膚科学)市場向け外用剤を開発・製造する製薬会社です。同社の製品には抗ニキビキット製剤や、BPO(過酸化ベンゾイル)ベースのニキビ治療薬を開発し、間もなく発売される予定です。また、酒さ治療の外用薬も開発しています。

当レポートでは、Sol-Gel Technologies Ltd.における治療薬開発パイプラインの現況と各開発段階の比較分析、薬剤標的、作用機序、投与経路、分子タイプ別の治療薬の評価、最新の企業ニュースや発表、後期段階および中止されたプロジェクトに関する情報などを提供しています。

Sol-Gel Technologies Ltd.の基本情報

Sol-Gel Technologies Ltd.の概要

  • 主要情報
  • 企業情報

Sol-Gel Technologies Ltd.:R&Dの概要

  • 主な治療範囲

Sol-Gel Technologies Ltd.:パイプラインのレビュー

  • 開発段階別のパイプライン製品
  • 単剤製品

Sol-Gel Technologies Ltd.:パイプライン製品の概況

  • 治験段階にあるパイプライン製品
    • 第II相にある製品/併用療法モダリティ
  • 初期段階にあるパイプライン製品
    • 前臨床段階にある製品/併用療法モダリティ

Sol-Gel Technologies Ltd.:薬剤プロファイル

  • DER-45EV
  • SGTSZ-91
  • SGTTN-65
  • 投与経路別

Sol-Gel Technologies Ltd.:休止中のプロジェクト

Sol-Gel Technologies Ltd.:本社と子会社の所在地

付録

図表一覧

目次
Product Code: GMDHC06099CDB

Summary

Global Markets Direct's, 'Sol-Gel Technologies Ltd. - Product Pipeline Review - 2014', provides an overview of the Sol-Gel Technologies Ltd.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Sol-Gel Technologies Ltd.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Sol-Gel Technologies Ltd. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Sol-Gel Technologies Ltd.'s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Sol-Gel Technologies Ltd.'s pipeline products

Reasons to buy

  • Evaluate Sol-Gel Technologies Ltd.'s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Sol-Gel Technologies Ltd. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Sol-Gel Technologies Ltd.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Sol-Gel Technologies Ltd. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Sol-Gel Technologies Ltd.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Sol-Gel Technologies Ltd. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Sol-Gel Technologies Ltd. Snapshot
    • Sol-Gel Technologies Ltd. Overview
    • Key Information
    • Key Facts
  • Sol-Gel Technologies Ltd. - Research and Development Overview
    • Key Therapeutic Areas
  • Sol-Gel Technologies Ltd. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • Sol-Gel Technologies Ltd. - Pipeline Products Glance
    • Sol-Gel Technologies Ltd. - Clinical Stage Pipeline Products
      • Phase II Products/Combination Treatment Modalities
    • Sol-Gel Technologies Ltd. - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
  • Sol-Gel Technologies Ltd. - Drug Profiles
    • DER-45EV
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • SGTSZ-91
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • SGTTN-65
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Sol-Gel Technologies Ltd. - Pipeline Products by Route of Administration
  • Sol-Gel Technologies Ltd. - Dormant Projects
  • Sol-Gel Technologies Ltd. - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Sol-Gel Technologies Ltd., Key Information
  • Sol-Gel Technologies Ltd., Key Facts
  • Sol-Gel Technologies Ltd. - Pipeline by Indication, 2014
  • Sol-Gel Technologies Ltd. - Pipeline by Stage of Development, 2014
  • Sol-Gel Technologies Ltd. - Monotherapy Products in Pipeline, 2014
  • Sol-Gel Technologies Ltd. - Phase II, 2014
  • Sol-Gel Technologies Ltd. - Preclinical, 2014
  • Sol-Gel Technologies Ltd. - Pipeline by Route of Administration, 2014
  • Sol-Gel Technologies Ltd. - Dormant Developmental Projects,2014

List of Figures

  • Sol-Gel Technologies Ltd. - Pipeline by Top 10 Indication, 2014
  • Sol-Gel Technologies Ltd. - Pipeline by Stage of Development, 2014
  • Sol-Gel Technologies Ltd. - Monotherapy Products in Pipeline, 2014
  • Sol-Gel Technologies Ltd. - Pipeline by Top 10 Route of Administration, 2014
Back to Top